These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7569425)

  • 61. Management of multidrug-resistant tuberculosis: Update 2007.
    Yew WW; Leung CC
    Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protocol for a population-based molecular epidemiology study of tuberculosis transmission in a high HIV-burden setting: the Botswana Kopanyo study.
    Zetola NM; Modongo C; Moonan PK; Click E; Oeltmann JE; Shepherd J; Finlay A
    BMJ Open; 2016 May; 6(5):e010046. PubMed ID: 27160840
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?
    Dubrovina I; Miskinis K; Lyepshina S; Yann Y; Hoffmann H; Zaleskis R; Nunn P; Zignol M
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):756-62. PubMed ID: 18544200
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of young children in household contact with adult multidrug-resistant pulmonary tuberculosis cases.
    Schaaf HS; Vermeulen HA; Gie RP; Beyers N; Donald PR
    Pediatr Infect Dis J; 1999 Jun; 18(6):494-500. PubMed ID: 10391177
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
    van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
    Wright A; Zignol M; Van Deun A; Falzon D; Gerdes SR; Feldman K; Hoffner S; Drobniewski F; Barrera L; van Soolingen D; Boulabhal F; Paramasivan CN; Kam KM; Mitarai S; Nunn P; Raviglione M;
    Lancet; 2009 May; 373(9678):1861-73. PubMed ID: 19375159
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management.
    Prasad R; Singh A; Balasubramanian V; Gupta N
    Indian J Med Res; 2017 Mar; 145(3):271-293. PubMed ID: 28749390
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Multidrug-resistant tuberculosis. 5. Human immunodeficiency virus infection and multidrug-resistant tuberculosis].
    Fujita A
    Kekkaku; 1998 Nov; 73(11):679-85. PubMed ID: 9866931
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The re-emergence of tuberculosis.
    Porter JD; McAdam KP
    Annu Rev Public Health; 1994; 15():303-23. PubMed ID: 8054087
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
    Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM
    Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
    Gandhi NR; Moll A; Sturm AW; Pawinski R; Govender T; Lalloo U; Zeller K; Andrews J; Friedland G
    Lancet; 2006 Nov; 368(9547):1575-80. PubMed ID: 17084757
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study.
    Becerra MC; Appleton SC; Franke MF; Chalco K; Arteaga F; Bayona J; Murray M; Atwood SS; Mitnick CD
    Lancet; 2011 Jan; 377(9760):147-52. PubMed ID: 21145581
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HIV and multidrug-resistant tuberculosis: overlapping epidemics.
    Dean AS; Zignol M; Falzon D; Getahun H; Floyd K
    Eur Respir J; 2014 Jul; 44(1):251-4. PubMed ID: 24525438
    [No Abstract]   [Full Text] [Related]  

  • 75. [Epidemiology of tuberculosis: new developments?].
    Schwoebel V
    Rev Med Interne; 1995; 16 Suppl 1():29s-32s. PubMed ID: 7652236
    [No Abstract]   [Full Text] [Related]  

  • 76. World must respond to threat of drug-resistant tuberculosis.
    Silversides A
    CMAJ; 2009 May; 180(10):E37. PubMed ID: 19433810
    [No Abstract]   [Full Text] [Related]  

  • 77. Optimal therapy for multidrug-resistant tuberculosis and HIV.
    Mayanja-Kizza H; Sekaggya-Wiltshire C; Kassa D
    Lancet; 2020 Aug; 396(10248):363-365. PubMed ID: 32771093
    [No Abstract]   [Full Text] [Related]  

  • 78. Reply to van Deun and Decroo.
    Cegielski JP; Udwadia ZF; Viiklepp P; Yim JJ; Menzies D
    Clin Infect Dis; 2021 Jun; 72(12):e1168-e1169. PubMed ID: 33341886
    [No Abstract]   [Full Text] [Related]  

  • 79. [A tuberculosis endemic in a mental institution].
    ROTACH F
    Schweiz Z Tuberk; 1945; 2(4):212-32. PubMed ID: 21022095
    [No Abstract]   [Full Text] [Related]  

  • 80. [American and Dutch tuberculosis mortality].
    RIJKELS DK
    Tegen Tuberc; 1949; 45(1):13-6. PubMed ID: 18144229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.